HomeNewsWorldCoronavirus pandemic | For HIV survivors, a feeling of weary déjà vu

Coronavirus pandemic | For HIV survivors, a feeling of weary déjà vu

COVID-19’s disproportionate ability to kill the poor, the uninsured and the elderly has also played into disheartening arguments against reacting aggressively. That has enraged a number of HIV survivors who have reached senior citizenship

April 11, 2020 / 15:24 IST
Story continues below Advertisement
FILE -- Act-Up members chain themselves together in the offices of a Japanese pharmaceutical company that said it would block the sale of a possible AIDS drug to American citizens in 1988. Some HIV survivors are experiencing a feeling of weary déjà vu during the coronavirus pandemic. (Sara Krulwich/The New York Times)
FILE -- Act-Up members chain themselves together in the offices of a Japanese pharmaceutical company that said it would block the sale of a possible AIDS drug to American citizens in 1988. Some HIV survivors are experiencing a feeling of weary déjà vu during the coronavirus pandemic. (Sara Krulwich/The New York Times)

Jacob Bernstein

Three weeks ago, a spring breaker in Miami became a symbol of Gen Z denialism when he spoke to CBS News and said that coronavirus wasn’t going to get in the way of his partying.

Story continues below Advertisement

Outrage was swift, but one person who felt a touch of recognition was Peter Staley, one of the country’s most respected AIDS activists.

Staley, 59, remembers what it was to be young and dumb.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show